Location Lausanne, Vaud, Switzerland Regions Europe, Middle East, and Africa (EMEA) Gender Male
LinkedIn View on LinkedIn
Andrew Sleight joined AB2 Bio in 2013 bringing with him over 25 years of experience in the Pharmaceutical Industry including 21 years with Roche where he was Global Therapeutic Area Head of Neuroscience.
While at Roche, he also held the positions of Chairman of the Neuroscience Strategy Committee and Global Head of Business Development for
Vascular and Metabolic Therapeutic Area.
Andrew holds a B.Sc from the University of Bath, a Ph.D. from the University of Nottingham and a Post-Doctoral Diploma from Stanford University.
